Commentary
Open Access
Medication Strategies for Childhood Diseases: Exploring Pharmacological Advancements, Evidence- Based Interventions, Safety Considerations, and Future Directions in Pediatric Therapeutics
Andrew Steller1*, O'Rourke Clark2, Marsh Young3
1Faculty of Graduate Studies and Research, University of Alberta, Edmonton, AB T6G 2E1, Canada
2Faculty of Health Disciplines, Athabasca University, Athabasca, AB T9S 3A3, Canada
3Faculty of Nursing, University of Alberta, Edmonton, AB T6G 1C9, Canada
Andrew Steller. Medication Strategies for Childhood Diseases: Exploring Pharmacological Advancements, Evidence- Based Interventions, Safety Considerations, and Future Directions in Pediatric Therapeutics.Int.J. MediPharm Res. 2025,11(2),pp 12-14
Abstract
The emergence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) created unprecedented challenges for healthcare delivery and professional education worldwide. Pharmacy education, particularly advanced experiential rotations, was profoundly affected by temporary hospital closures and restricted clinical access. This commentary reflects on the adaptations, lessons learned, and innovative strategies implemented during an evidence-based pharmacy practice rotation in response to the MERS-CoV epidemic. Through adaptive learning approaches, virtual engagement, and reflective practice, pharmacy students maintained continuity of experiential education while contributing meaningfully to clinical understanding and public health preparedness. Insights from this period highlight critical strategies for enhancing resilience in pharmacy education during future public health crises.
Keywords
Experiential pharmacy education, MERS-CoV, pandemic, clinical site closures, virtual learning, evidence-based practice, simulation-based learning, public health integration, pharmacy curriculum, student competency.